跳转至内容
Merck
CN
  • Aerobic exercise training increases plasma Klotho levels and reduces arterial stiffness in postmenopausal women.

Aerobic exercise training increases plasma Klotho levels and reduces arterial stiffness in postmenopausal women.

American journal of physiology. Heart and circulatory physiology (2013-12-11)
Tomoko Matsubara, Asako Miyaki, Nobuhiko Akazawa, Youngju Choi, Song-Gyu Ra, Koichiro Tanahashi, Hiroshi Kumagai, Satoshi Oikawa, Seiji Maeda
摘要

The Klotho gene is a suppressor of the aging phenomena, and the secretion as well as the circulation of Klotho proteins decrease with aging. Although habitual exercise has antiaging effects (e.g., a decrease in arterial stiffness), the relationship between Klotho and habitual exercise remains unclear. In the present study, we investigated the effect of habitual exercise on Klotho, with a particular focus on arterial stiffness. First, we examined the correlation between plasma Klotho concentration and arterial stiffness (carotid artery compliance and β-stiffness index) or aerobic exercise capacity [oxygen uptake at ventilatory threshold (VT)] in 69 healthy, postmenopausal women (50-76 years old) by conducting a cross-sectional study. Second, we tested the effects of aerobic exercise training on plasma Klotho concentrations and arterial stiffness. A total of 19 healthy, postmenopausal women (50-76 years old) were divided into two groups: control group and exercise group. The exercise group completed 12 wk of moderate aerobic exercise training. In the cross-sectional study, plasma Klotho concentrations positively correlated with carotid artery compliance and VT and negatively correlated with the β-stiffness index. In the interventional study, aerobic exercise training increased plasma Klotho concentrations and carotid artery compliance and decreased the β-stiffness index. Moreover, the changes in plasma Klotho concentration and arterial stiffness were found to be correlated. These results suggest a possible role for secreted Klotho in the exercise-induced modulation of arterial stiffness.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type HP-2, aqueous solution, ≥100,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, Type IX-A, lyophilized powder, 1,000,000-5,000,000 units/g protein (30 min assay)
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于帽贝 (Patella vulgata), Type L-II, lyophilized powder, 1,000,000-3,000,000 units/g solid
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, Type VII-A, lyophilized powder, 5,000,000-20,000,000 units/g protein, pH 6.8 (30 min assay)
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type H-2, aqueous solution, ≥85,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type H-1, partially purified powder, ≥300,000 units/g solid
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于牛肝脏, Type B-1, ≥1,000,000 units/g solid
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type H-5, lyophilized powder, ≥400,000 units/g solid
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, >20,000,000 units/g protein, recombinant, expressed in E. coli, aqueous glycerol solution
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type H-3, aqueous solution, ≥90,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type HP-2S, aqueous solution, ≥90,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, ≥10,000,000 units/g protein (30 min assay), recombinant, expressed in E. coli overproducing strain, lyophilized powder
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, ≥20,000 units/mg protein, recombinant, expressed in E. coli overproducing strain, lyophilized powder
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于大肠杆菌, aqueous glycerol solution, ≥5,000,000 units/g protein, pH 6.8 (biuret)
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于牛肝脏, Type B-3, ≥2,000,000 units/g solid
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于帽贝 (Patella vulgata), aqueous solution, ≥85,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于罗曼蜗牛, Type H-3AF, aqueous solution, ≥60,000 units/mL
Sigma-Aldrich
β-葡萄糖醛酸酶 来源于散大蜗牛 (花园蜗牛), Type HA-4